All Stories

  1. <i>In silico</i> analysis reveals distinct changes in markers of epithelial to mesenchymal transition in glioma subtypes
  2. Expression of Wnt signaling proteins LEF1, β-catenin, GSK3β, DVL1, and N-myc varies across retinoblastoma subtypes and pRb phosphorylation status
  3. SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter
  4. Glioma Stem Cells—Features for New Therapy Design
  5. Genetics in ophthalmology: molecular blueprints of retinoblastoma
  6. Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment
  7. Different Approaches to Study Molecular Blueprint and Biological Behavior of Brain Tumors: Editorial to the Special Issue “Advances in Molecular Genetics of Brain Tumors”
  8. Bilateral Meningioma: A Case Report and Review of the Literature
  9. Decoding the Role of DVL1 in Intracranial Meningioma
  10. Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain
  11. Methylation Patterns of DKK1, DKK3 and GSK3β Are Accompanied with Different Expression Levels in Human Astrocytoma
  12. Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression
  13. TWIST1 upregulation affects E-cadherin expression in brain metastases
  14. Mismatch Repair Pathway, Genome Stability and Cancer
  15. Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in�silico prediction of their significance
  16. Comparable Genomic Copy Number Aberrations Differ across Astrocytoma Malignancy Grades
  17. Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation
  18. Comparable genomic copy number aberrations differ across astrocytoma malignancy grades
  19. Secreted Frizzled Related Protein 1 a molecule that is downregulated
  20. 74PPromoter hypermethylation of Wnt pathway inhibitor SFRP1 gene and its expression levels in human astrocytomas
  21. Mismatch repair in meningioma
  22. Molecules of wnt signaling involvement in glioblastoma
  23. AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin
  24. Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling
  25. Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression
  26. Expression patterns of Wnt signaling component, secreted frizzled-related protein 3 in astrocytoma and glioblastoma
  27. Wnt signaling and astrocytic brain tumors
  28. Only one health, and so many omics
  29. Tracing the genetic origin of Europe's first farmers reveals insights into their social organization
  30. Roles of lncRNA in breast cancer
  31. aCGH analysis of adult pilocytic astroytoma
  32. Proteins Dishevelled components of Wnt signaling
  33. Tracing the genetic origin of Europe's first farmers reveals insights into their social organization
  34. Brain Metastases from Lung Cancer Show Increased Expression of DVL1, DVL3 and Beta-Catenin and Down-Regulation of E-Cadherin
  35. Merlin, the NF2 Gene Product
  36. SFRP1, SFRP3, TCF1 and LEF1 in renal cell carcinoma
  37. Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients
  38. AXIN1 (axin 1)
  39. Epithelial-to-mesenchymal transition possible role in meningiomas
  40. Meningiomas: Role of Genetic Instabilities of the E-cadherin Gene
  41. Brain metastases exhibit gross deletions of the APC gene
  42. Molecular alterations of E-cadherin and beta-catenin in brain metastases
  43. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors
  44. Wnt signal transduction pathway and apoptosis: a review
  45. Loss of heterozygosity of CDKN2A (p16INK4a) and RB1 tumor suppressor genes in testicular germ cell tumors
  46. Genetic and protein changes of E-cadherin in meningiomas
  47. Report on mutation in exon 15 of the APC gene in a case of brain metastasis
  48. Changes of AXIN-1 and Beta-Catenin in Neuroepithelial Brain Tumors
  49. Analysis of Selected Genes in Neuroendocrine Tumours: Insulinomas and Phaeochromocytomas
  50. Meningiomas exhibit loss of heterozygosity of the APC gene
  51. Genetic alterations of E-cadherin and beta-catenin in germinoma and teratoma: Report of two central nervous system cases
  52. Genetic changes of CDH1, APC, and CTNNB1 found in human brain tumors
  53. Identification and analysis of human remains recovered from wells from the 1991 War in Croatia
  54. Biological mechanisms of bone and cartilage remodelling—genomic perspective
  55. E-cadherin and ?-catenin expression patterns in malignant melanoma assessed by image analysis
  56. Loss of heterozygosity of the APC gene found in a single case of oligoastrocytoma
  57. Loss of heterozygosity of APC and CDH1 genes in laryngeal squamous cell carcinoma
  58. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma
  59. Life stress on the Roman limes in continental Croatia
  60. Tumor suppressor gene E-cadherin and its role in normal and malignant cells.
  61. Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas
  62. Nested Polymerase Chain Reaction for Detection of Hepatitis C Virus RNA in Blood Derivatives
  63. Influence of angular misorientation of thin Sn/SnTe bilayers of the fine structure of electron diffraction patterns
  64. The many-beam moiré effect in electron micrographs of epitaxic Sn/SnTe layers